Ireland - English - HPRA (Health Products Regulatory Authority)

ecuphar nv - cefalexin monohydrate - tablet - 250 mg/tablet - cefalexin

Ireland - English - HPRA (Health Products Regulatory Authority)

ecuphar nv - cefalexin monohydrate - tablet - 50 mg/tablet - cefalexin

Ireland - English - HPRA (Health Products Regulatory Authority)

ecuphar nv - cefalexin monohydrate - tablet - 500 mg/tablet - cefalexin

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 4 mg; benzydamine hydrochloride, quantity: 3 mg; dichlorobenzyl alcohol, quantity: 1.2 mg - lozenge - excipient ingredients: isomalt; citric acid; aspartame; acesulfame potassium; amaranth; flavour - for the relief of the major symptoms associated with sore throat. reduces inflammation and relieves pain for fast effective relief of symptoms of a sore throat, oral surgery, minor mouth infections and dental procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate (equivalent: amoxicillin, qty mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; iron oxide yellow; titanium dioxide; gelatin - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriologic studies including sensitivity tests and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative agent has yet to be identified. respiratory tract infections (acute and chronic): h, influenzae; streptococcus; s. pneumoniae; staphylococcus, non-pencillinase producing; e. coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic): e, coli (see microbiology); p. mirabilis; s. faecalis. gonorrhoea (n.gonorrhoeae, non-penicillinase producing). skin and skin structure infections: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see microbiology). prophylaxis of endocarditis. amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis. infections caused by pathogens with established penicillin g susceptibility should preferentially be treated with penicillin g.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate (equivalent: amoxicillin, qty mg) - capsule, hard - excipient ingredients: magnesium stearate; microcrystalline cellulose; iron oxide yellow; titanium dioxide; gelatin - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriologic studies including sensitivity tests and by clinical response. amoxycillin, alone or in combination with another antibiotic, may be used in an emergency where the causative agent has yet to be identified. respiratory tract infections: (acute and chronic): h.influenzae; streptococcus; s.pneumoniae; staphylococcus, non-penicillinase producing; e.coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic) e.coli (see microbiology); p.mirabilis; s.faecalis. gonorrhoea (n.gonorrhoeae, non-penicillinase producing). skin and skin structure infections: staaphylococcus, non-penicillinase producing: streptococcus: e.coli (see microbiology). prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis. infections caused by pathgogens with established pencicillin g susceptibility should be preferentially treated with penicillin g.

Australia - English - Department of Health (Therapeutic Goods Administration)

care pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 1 mg/ml; paracetamol, quantity: 24 mg/ml; promethazine hydrochloride, quantity: 1.3 mg/ml - oral liquid, solution - excipient ingredients: purified water; sodium metabisulfite; sorbitol solution (70 per cent) (non-crystallising); propylene glycol; sucrose; disodium edetate; saccharin sodium; brilliant blue fcf; amaranth; phosphoric acid; ethanol; flavour - for the temporary relief of acute moderate pain when paracetamol alone is not sufficient and sedation is considered beneficial in patients over the age of 12 years ( see also contraindications and paediatric use)

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

gba corporation sdn. bhd. - menthol flavour powder -

Ireland - English - HPRA (Health Products Regulatory Authority)

ecuphar nv - doxycycline hyclate - tablet - 200 mg/tablet - doxycycline

Ireland - English - HPRA (Health Products Regulatory Authority)

ecuphar nv - doxycycline hyclate - tablet - 40 mg/tablet - doxycycline